Literature DB >> 16782905

Non-islet-cell tumor induced hypoglycemia in patients with advanced gastrointestinal stromal tumor possibly worsened by imatinib.

Paul Hamberg, Floris A de Jong, Joke G Boonstra, Jaap van Doorn, Jaap Verweij, Stefan Sleijfer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16782905     DOI: 10.1200/JCO.2006.06.5318

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  13 in total

1.  Hypoglycaemia in a 63-year-old female with a large, recurrent, metastatic gastrointestinal stromal tumour (GIST).

Authors:  Grace Tan; Melissa Teo; Su Pin Choo
Journal:  J Gastrointest Cancer       Date:  2011-12

2.  Patterns of deregulation of insulin growth factor signalling pathway in paediatric and adult gastrointestinal stromal tumours.

Authors:  Antoine Italiano; Junwei Chen; Lei Zhang; Mihai Hajdu; Samuel Singer; Ronald P DeMatteo; Cristina R Antonescu
Journal:  Eur J Cancer       Date:  2012-07-04       Impact factor: 9.162

Review 3.  Endocrine side effects of broad-acting kinase inhibitors.

Authors:  Maya B Lodish; Constantine A Stratakis
Journal:  Endocr Relat Cancer       Date:  2010-08-16       Impact factor: 5.678

Review 4.  Cardio-onco-metabolism: metabolic remodelling in cardiovascular disease and cancer.

Authors:  Anja Karlstaedt; Javid Moslehi; Rudolf A de Boer
Journal:  Nat Rev Cardiol       Date:  2022-04-19       Impact factor: 32.419

Review 5.  Clinical review: kinase inhibitors: adverse effects related to the endocrine system.

Authors:  Maya B Lodish
Journal:  J Clin Endocrinol Metab       Date:  2013-02-28       Impact factor: 5.958

6.  PPARγ Antagonist Gleevec Improves Insulin Sensitivity and Promotes the Browning of White Adipose Tissue.

Authors:  Sun-Sil Choi; Eun-Sun Kim; Ji-Eun Jung; David P Marciano; Ala Jo; Ja Young Koo; Soo Youn Choi; Yong Ryoul Yang; Hyun-Jun Jang; Eung-Kyun Kim; Jiyoung Park; Hyug Moo Kwon; In Hee Lee; Seung Bum Park; Kyung-Jae Myung; Pann-Ghill Suh; Patrick R Griffin; Jang Hyun Choi
Journal:  Diabetes       Date:  2016-01-06       Impact factor: 9.461

7.  Symptomatic hypoglycemia during imatinib mesylate in a non-diabetic female patient with gastrointestinal stromal tumor.

Authors:  M Haap; B Gallwitz; C Thamer; K Müssig; H-U Häring; L Kanz; J T Hartmann
Journal:  J Endocrinol Invest       Date:  2007-09       Impact factor: 4.256

Review 8.  Management of non-islet-cell tumor hypoglycemia: a clinical review.

Authors:  Timothy W Bodnar; Maria J Acevedo; Massimo Pietropaolo
Journal:  J Clin Endocrinol Metab       Date:  2013-12-11       Impact factor: 5.958

9.  Blood glucose levels in patients with metastatic renal cell carcinoma treated with sunitinib.

Authors:  B Billemont; J Medioni; L Taillade; D Helley; J B Meric; O Rixe; S Oudard
Journal:  Br J Cancer       Date:  2008-10-07       Impact factor: 7.640

10.  Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec, Gleevectrade mark).

Authors:  Martin Henkes; Heiko van der Kuip; Walter E Aulitzky
Journal:  Ther Clin Risk Manag       Date:  2008-02       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.